Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-08

Clinical Trial Update: Efficacy of Gabapentin in Treating Pain in Children With SNI (Gabapentin Trial) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating gabapentin for neuropathic pain in children and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: University of British Columbia | Conditions: Pain, Neuropathic Pain | Phase 2 | Status: RECRUITING